Joyce Shedrick

NPI: 1750866414
Total Payments
$4,375
2024 Payments
$699.20
Companies
16
Transactions
206
Medicare Patients
1,333
Medicare Billing
$92,981

Payment Breakdown by Category

Food & Beverage$4,361 (99.7%)
Education$13.76 (0.3%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $4,361 205 99.7%
Education $13.76 1 0.3%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $1,515 58 $0 (2024)
Gilead Sciences, Inc. $822.84 31 $0 (2024)
Janssen Biotech, Inc. $764.51 35 $0 (2024)
RedHill Biopharma Inc. $372.86 31 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $153.45 9 $0 (2024)
Phathom Pharmaceuticals, Inc. $152.75 10 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $148.04 9 $0 (2024)
IRONWOOD PHARMACEUTICALS, INC $135.64 7 $0 (2024)
Evoke Pharma, Inc. $69.85 4 $0 (2022)
Merck Sharp & Dohme LLC $66.36 3 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $699.20 35 Janssen Biotech, Inc. ($244.06)
2023 $1,570 54 ABBVIE INC. ($718.36)
2022 $972.50 42 ABBVIE INC. ($426.59)
2021 $1,133 75 AbbVie Inc. ($295.08)

All Payment Transactions

206 individual payment records from CMS Open Payments — Page 1 of 9

Date Company Product Nature Form Amount Type
12/19/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $10.79 General
Category: Immunology
11/15/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $19.13 General
Category: GASTROENTEROLOGY
11/07/2024 PFIZER INC. XELJANZ (Drug), VELSIPITY Food and Beverage In-kind items and services $23.97 General
Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT
10/16/2024 Janssen Biotech, Inc. TREMFYA (Drug), STELARA Food and Beverage In-kind items and services $145.91 General
Category: Immunology
10/16/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $15.56 General
Category: Immunology
10/03/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $17.59 General
Category: Immunology
08/23/2024 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $5.50 General
Category: Immunology
08/22/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $7.99 General
Category: GASTROENTEROLOGY
08/20/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $17.97 General
08/02/2024 RedHill Biopharma Inc. Talicia (Drug) Food and Beverage Cash or cash equivalent $19.63 General
Category: Antibiotic
08/02/2024 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $12.06 General
Category: Immunology
07/30/2024 Takeda Pharmaceuticals U.S.A., Inc. EOHILIA (Drug) Education In-kind items and services $13.76 General
Category: INTERNAL MEDICINE
07/24/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $25.71 General
Category: GASTROENTEROLOGY
07/24/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $4.31 General
Category: GASTROENTEROLOGY
07/09/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC TRULANCE (Drug) Food and Beverage In-kind items and services $21.64 General
Category: Gastroenterology
06/13/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $17.24 General
Category: GASTROENTEROLOGY
06/07/2024 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $16.19 General
Category: Immunology
06/04/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $9.81 General
Category: GASTROENTEROLOGY
06/03/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC TRULANCE (Drug) Food and Beverage In-kind items and services $14.98 General
Category: Gastroenterology
05/22/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $19.85 General
05/15/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $11.73 General
Category: GASTROENTEROLOGY
05/01/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $27.62 General
Category: GASTROENTEROLOGY
04/30/2024 ABBVIE INC. MAVYRET (Drug) Food and Beverage In-kind items and services $15.96 General
Category: VIROLOGY
04/26/2024 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $9.98 General
Category: Immunology
04/11/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $13.63 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 262 346 $54,550 $20,154
2022 2 300 424 $58,250 $24,738
2021 4 350 398 $55,610 $25,341
2020 6 421 467 $63,825 $22,747
Total Patients
1,333
Total Services
1,635
Medicare Billing
$92,981
Procedure Codes
14

All Medicare Procedures & Services

14 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 191 275 $38,000 $15,648 41.2%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 71 71 $16,550 $4,506 27.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 195 319 $39,875 $18,495 46.4%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 105 105 $18,375 $6,243 34.0%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 147 181 $22,625 $10,983 48.5%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 85 98 $13,720 $7,664 55.9%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 93 93 $16,275 $6,227 38.3%
98967 Telephone assessment and management service, 11-20 minutes of medical discussion Office 2021 25 26 $2,990 $467.75 15.6%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 186 230 $28,750 $10,083 35.1%
99203 New patient office or other outpatient visit, typically 30 minutes Office 2020 103 103 $18,025 $6,646 36.9%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 57 58 $8,120 $4,436 54.6%
98967 Telephone assessment and management service, 11-20 minutes of medical discussion Office 2020 42 42 $4,830 $806.11 16.7%
98968 Telephone assessment and management service, 21-30 minutes of medical discussion Office 2020 19 19 $2,375 $425.79 17.9%
99212 Established patient office or other outpatient visit, typically 10 minutes Office 2020 14 15 $1,725 $349.86 20.3%

About Joyce Shedrick

Joyce Shedrick is a Nurse Practitioner healthcare provider based in Pasadena, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2018. The National Provider Identifier (NPI) number assigned to this provider is 1750866414.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Joyce Shedrick has received a total of $4,375 in payments from pharmaceutical and medical device companies, with $699.20 received in 2024. These payments were reported across 206 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($4,361).

As a Medicare-enrolled provider, Shedrick has provided services to 1,333 Medicare beneficiaries, totaling 1,635 services with total Medicare billing of $92,981. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.

Practice Information

  • Specialty Nurse Practitioner
  • Location Pasadena, TX
  • Active Since 09/28/2018
  • Last Updated 12/31/2020
  • Taxonomy Code 363L00000X
  • Entity Type Individual
  • NPI Number 1750866414

Products in Payments

  • RINVOQ (Biological) $454.31
  • MAVYRET (Drug) $378.18
  • REMICADE (Biological) $363.48
  • Talicia (Drug) $292.14
  • HUMIRA (Biological) $273.17
  • Vemlidy (Drug) $226.17
  • STELARA (Biological) $211.18
  • LINZESS (Drug) $200.02
  • TREMFYA (Drug) $189.85
  • CREON (Drug) $158.49
  • VOQUEZNA (Drug) $152.75
  • Linzess (Drug) $135.64
  • ENTYVIO (Biological) $87.91
  • Epclusa (Drug) $85.73
  • XIFAXAN (Drug) $80.72
  • TRULANCE (Drug) $72.73
  • GIMOTI (Drug) $69.85
  • DIFICID (Drug) $66.36
  • VIBERZI (Drug) $51.21
  • XELJANZ (Drug) $44.56

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nurse Practitioner Doctors in Pasadena